作者
Veronique Sans, Eric Dumas de la Roque, Jérôme Berge, Nicolas Grenier, Franck Boralevi, Juliette Mazereeuw-Hautier, Dan Lipsker, Elisabeth Dupuis, Khaled Ezzedine, Pierre Vergnes, Alain Taïeb, Christine Léauté-Labrèze
发表日期
2009/9/1
期刊
Pediatrics
卷号
124
期号
3
页码范围
e423-e431
出版商
American Academy of Pediatrics
简介
OBJECTIVE: Infantile hemangiomas (IHs) are the most-common soft-tissue tumors of infancy. We report the use of propranolol to control the growth phase of IHs.
METHODS: Propranolol was given to 32 children (21 girls; mean age at onset of treatment: 4.2 months) after clinical and ultrasound evaluations. After electrocardiographic and echocardiographic evaluations, propranolol was administered with a starting dose of 2 to 3 mg/kg per day, given in 2 or 3 divided doses. Blood pressure and heart rate were monitored during the first 6 hours of treatment. In the absence of side effects, treatment was continued at home and the child was reevaluated after 10 days of treatment and then every month. Ultrasound measurements were performed after 60 days of treatment.
RESULTS: Immediate effects on color and growth were noted in all cases and were especially dramatic in cases of dyspnea …
引用总数
200920102011201220132014201520162017201820192020202120222023202434012593112936473323525152317153
学术搜索中的文章
V Sans, ED de la Roque, J Berge, N Grenier, F Boralevi… - Pediatrics, 2009